These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 35331169)

  • 1. Pan-cancer analysis identifies BIRC5 as a prognostic biomarker.
    Fäldt Beding A; Larsson P; Helou K; Einbeigi Z; Parris TZ
    BMC Cancer; 2022 Mar; 22(1):322. PubMed ID: 35331169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of prognostic significance of BIRC5 in breast cancer using integrative bioinformatics analysis.
    Dai JB; Zhu B; Lin WJ; Gao HY; Dai H; Zheng L; Shi WH; Chen WX
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32043523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Role of Survivin and Macrophage Infiltration Quantified on Protein and mRNA Level in Molecular Subtypes Determined by RT-qPCR of
    Ecke TH; Kiani A; Schlomm T; Friedersdorff F; Rabien A; Jung K; Kilic E; Boström P; Tervahartiala M; Taimen P; Gleichenhagen J; Johnen G; Brüning T; Koch S; Roggisch J; Wirtz RM
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33050010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Value of BIRC5 in Lung Adenocarcinoma Lacking EGFR, KRAS, and ALK Mutations by Integrated Bioinformatics Analysis.
    Cao Y; Zhu W; Chen W; Wu J; Hou G; Li Y
    Dis Markers; 2019; 2019():5451290. PubMed ID: 31093306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrative Histologic and Bioinformatics Analysis of BIRC5/Survivin Expression in Oral Squamous Cell Carcinoma.
    Troiano G; Guida A; Aquino G; Botti G; Losito NS; Papagerakis S; Pedicillo MC; Ionna F; Longo F; Cantile M; Pennella A; Lo Russo L; Di Gioia G; Mariggiò MA; Lo Muzio L; Pannone G
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30205554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysregulation of miR-195-5p/-218-5p/BIRC5 axis predicts a poor prognosis in patients with gastric cancer.
    Zou J; Liao X; Zhang J; Wang L
    J Biol Regul Homeost Agents; 2019; 33(5):1377-1385. PubMed ID: 31663299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BIRC5 is a prognostic biomarker associated with tumor immune cell infiltration.
    Xu L; Yu W; Xiao H; Lin K
    Sci Rep; 2021 Jan; 11(1):390. PubMed ID: 33431968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survivin' Acute Myeloid Leukaemia-A Personalised Target for inv(16) Patients.
    Greiner J; Brown E; Bullinger L; Hills RK; Morris V; Döhner H; Mills KI; Guinn BA
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterisation of TP53 mutated squamous cell carcinomas of the lung to identify putative targets for therapy.
    Haakensen VD; Khadse A; Sandhu V; Halvorsen AR; Solberg SK; Jørgensen LH; Brustugun OT; Kure EH; Helland Å
    Int J Cancer; 2020 Nov; 147(10):2957-2966. PubMed ID: 32468587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Pan-Cancer Analysis of the BIRC Gene Family and Its Association with Prognosis, Tumor Microenvironment, and Therapeutic Targets.
    Wu S; Zang Q; Xing Z; Li X; Leng J; Liu Y; Wang X; Yang J
    Crit Rev Eukaryot Gene Expr; 2021; 31(4):35-48. PubMed ID: 34587434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical value of survivin and its underlying mechanism in ovarian cancer: A bioinformatics study based on GEO and TCGA data mining.
    Li XJ; Pang JS; Li YM; Ahmed FA; He RQ; Ma J; Ma FC; Chen G
    Pathol Res Pract; 2018 Mar; 214(3):385-401. PubMed ID: 29499854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of prognostic markers for hepatocellular carcinoma based on the epithelial-mesenchymal transition-related gene BIRC5.
    Xu R; Lin L; Zhang B; Wang J; Zhao F; Liu X; Li Y; Li Y
    BMC Cancer; 2021 Jun; 21(1):687. PubMed ID: 34112092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BIRC5 Gene Disruption via CRISPR/Cas9n Platform Suppress Acute Myelocytic Leukemia Progression.
    Narimani M; Sharifi M; Hakhamaneshi MS; Roshani D; Kazemi M; Hejazi SH; Jalili A
    Iran Biomed J; 2019 Nov; 23(6):369-78. PubMed ID: 31104397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BIRC5 expression by race, age and clinical factors in breast cancer patients.
    Hamilton AM; Walens A; Van Alsten SC; Olsson LT; Nsonwu-Farley J; Gao X; Kirk EL; Perou CM; Carey LA; Troester MA; Abdou Y
    Breast Cancer Res; 2024 Mar; 26(1):50. PubMed ID: 38515208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploration of the Tumor Mutational Burden as a Prognostic Biomarker and Related Hub Gene Identification in Prostate Cancer.
    Wang L; Yao Y; Xu C; Wang X; Wu D; Hong Z
    Technol Cancer Res Treat; 2021; 20():15330338211052154. PubMed ID: 34806485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survivin in Breast Cancer: A Review.
    Martínez-Sifuentes MA; Bassol-Mayagoitia S; Nava-Hernández MP; Ruiz-Flores P; Ramos-Treviño J; Haro-Santa Cruz J; Hernández-Ibarra JA
    Genet Test Mol Biomarkers; 2022 Sep; 26(9):411-421. PubMed ID: 36166738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of cytoplasmic-to-nuclear ratio of survivin as an indicator of improved prognosis in breast cancer.
    Rexhepaj E; Jirstrom K; O'Connor DP; O'Brien SL; Landberg G; Duffy MJ; Brennan DJ; Gallagher WM
    BMC Cancer; 2010 Nov; 10():639. PubMed ID: 21092276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BIRC5 Genomic Copy Number Variation in Early-Onset Breast Cancer.
    Ghaffari K; Hashemi M; Ebrahimi E; Shirkoohi R
    Iran Biomed J; 2016 Sep; 20(4):241-5. PubMed ID: 27372966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of prognostic gene signature for basal-like breast cancer and high-grade serous ovarian cancer.
    Zhang Y; Liu J; Raj-Kumar PK; Sturtz LA; Praveen-Kumar A; Yang HH; Lee MP; Fantacone-Campbell JL; Hooke JA; Kovatich AJ; Shriver CD; Hu H
    Breast Cancer Res Treat; 2020 Dec; 184(3):689-698. PubMed ID: 32880016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pan-cancer analysis of genomic and transcriptomic data reveals the prognostic relevance of human proteasome genes in different cancer types.
    Larsson P; Pettersson D; Engqvist H; Werner Rönnerman E; Forssell-Aronsson E; Kovács A; Karlsson P; Helou K; Parris TZ
    BMC Cancer; 2022 Sep; 22(1):993. PubMed ID: 36123629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.